MedPath

Single Adductor-canal-block Versus Peri-articular Infiltration on Outcome After Total Knee Arthroplasty

Not Applicable
Conditions
Osteoarthritis,Knee
Interventions
Drug: single adductor-canal-block
Drug: periarticular infiltration
Registration Number
NCT02784041
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

The purpose of this study is to compare the effect of single adductor-canal-block versus single femoral nerve block on the recovery after total knee arthroplasty.

Detailed Description

The aim of this study is to assess the effect of different analgesic effects on the outcome of patients undergoing total knee arthroplasty. Patients who will have primary unilateral total knee replacement between September 2016 to June 2018 at Peking Union Medical College Hospital and meet the inclusion criteria will be included. They are randomized into two groups. The total knee arthroplasty is performed by one surgeon and adductor-canal block is performed by one anesthesiologist who is not responsible for follow-up. Patients on both groups will have intravenous patient control analgesia with 1 mg morphine/bolus. One residency is responsible for the follow-up.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  • osteoarthritis
  • unilateral total knee arthroplasty
  • ASA grade I - II
  • normal cognitive function.
Exclusion Criteria
  • patients refuse
  • BMI > 35
  • diagnosis other than osteoarthritis
  • allergy to the drugs used or contraindication to the intervention

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
single adductor-canal-blocksingle adductor-canal-blockPatients in this group will receive ultrasound guided single adductor-canal- block with 0.35% ropivacaine 25ml.
periarticular infiltrationperiarticular infiltrationpatients in this group will receive periarticular infiltration of local anesthetic.
Primary Outcome Measures
NameTimeMethod
the time required for functional recoveryfrom the date of the surgery to the time when the patients meet the criteria of functional recovery. The earliest day on which the patient achieves the criteria of functional recovery will be recorded and the average time is 7 days after surgery.

Patients are evaluated postoperatively to determine whether the patients have meet the criteria of functional recovery.The criteria of functional recovery are as followings: walking distance more than 70m with crutch, getting up or standing up independently and visual analog score less than 5 both in rest and after movement. Before discharge, patients are assessed every morning. After discharge, patients are followed up by phone every two days.

Secondary Outcome Measures
NameTimeMethod
postoperative morphine consumption6h, 24h, 48h after the surgery

Consumptions of morphine are recorded at 6h, 24h, 48h after the surgery.

postoperative WOMAC scalespre-operative, three months,six months and one year afer the surgery

We compare the WOMAC scales of two groups before, three months, six months, and one year after the surgery.

Postoperative complicationsdaily after the surgery until discharge from hospital, expected average up to 5 days after the surgery

Any complication, including nause and vomiting, deep vein thrombosis, pulmonary embolism, pulmonary infection, urinary tract infection,cardiovascular event and falls are recorded during inhospital stay.

postoperative VAS scalepre-operative, 6h postoperative, 24h postoperative, 48h postoperative, one month postoperative, three-month postoperative, one year postoperative

Pain at rest and while moving are evaluated by a visual analog scale preoperative, 6h, 24h, 48h, 1month, 3 months and 1 year after the surgery.

postoperative SF-36 scorepre-operative, three months,six months and one year afer the surgery

We compare the SF-36 score of two groups before, three months,six months and one year after the surgery.

Trial Locations

Locations (1)

Peking Union Medical College Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath